Actinogen Medical (ACW.AX) Earnings Analysis
Actinogen Medical (ACW.AX) next reports earnings on 2026-08-31. Trailing P/E -7.24.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ACW.AX next report earnings?
| Next earnings date | 2026-08-31 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
ACW.AX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-25 | -0.0036 AUD | n/a | n/a | n/a |
| 2025-08-25 | -0.00216 AUD | n/a | n/a | n/a |
| 2025-02-24 | -0.0028 AUD | n/a | n/a | n/a |
| 2024-10-30 | -0.00065 AUD | n/a | n/a | n/a |
ACW.AX valuation and analyst view
| Trailing P/E | -7.24 |
|---|---|
| Trailing EPS | -0.00562 AUD |
| Price / book | 15.99 |
| Dividend yield | 0.00% |
| Market cap | 0.15B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Actinogen Medical (ACW.AX)'s next earnings date?
Actinogen Medical is next scheduled to report on 2026-08-31.
Did ACW.AX beat earnings last quarter?
Consensus estimate data was not available for ACW.AX's 2026-02-25 report.
What is ACW.AX's current P/E ratio and EPS?
ACW.AX trades at a trailing P/E of -7.24 on trailing EPS of -0.005619961288453253 AUD.
What do analysts rate ACW.AX?
ACW.AX has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.